Skip to main content

Table 3 10-year Monte-Carlo simulation outcomes

From: Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France

Monte-Carlo simulations (N = 30,000) No-treatment Real-world persistence Ideal persistence
Clinical fractures Vertebrae 8,193 6,308 3,912
  Hip 5,534 4,462 3,313
  Wrist 6,674 5,941 5,153
  Total 20,401 16,711 12,378
Fractured women
(proportion)
20,131
(67,1%)
17,996
(60.0%)
14,715
(49.1%)
Deaths
(proportion)
1,816
(6.1%)
1,466
(4.9%)
1,015
(3.4%)
\